drugset
drugset / Trial / NCT06703463

A Drug-Drug Interaction Study of Diltiazem and MK-1167 in Healthy Adult Participants (MK-1167-006)

NCT06703463 ↗

Phase 1 Completed 16 enrolled Merck Sharp & Dohme LLC
Non-randomizedSequentialOpen-labelBasic science

Summary

The goal of this study this study is to learn about the safety of MK-1167 and if people tolerate it. Researchers will compare what happens to MK-1167 in the body when it is given with and without another medicine called diltiazem.

Timeline

Start
2023-10-17
Primary completion
2024-02-02
Completion
2024-02-02

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-1167 Unknown — Oral
Background Diltiazem Small molecule 240 mg Oral

Indications

No indication recorded.